Yulia Nedelcheva


The aim of the paper is to present the key periods of competitiveness dynamics in pharmaceutical industry. The historical overview covers the emergence of modern pharmaceutical industry. Given the role of pharmaceutical industry in healthcare, particular attention is paid to the impact of state supervision on dynamics.
The results of the paper determinate ten periods in the dynamics of competitiveness. Both internal factors of competitiveness and external factors are presented. Competitiveness of pharmaceutical industry marks a dynamics that is similar to that of other sciences and at each period, a new factor is added from the external environment.



state supervision; competitive advantage; path dependence


JEL Codes: D24, L65, N80



Borisova, L. (2017). Problems of public communication. Economics and Management, XIII(2): 128-139 (in Bulgarian)
Congressional Budget Office. (2006). Research and Development in the Pharmaceutical Industry. Washington
Daemmrich, A., M. Bowden. (2005). A Rising Drug Industry: Pharmaceuticals since 1870. Chemical and Engineering News, 83(25): 28-42
European Commission. (1996). Europe's pharmaceutical industry: An innovation profile. European Information Monitoring System (EIMS). EIMS Publication No. 32
European Commission. (2012). A Stronger European Industry for Growth and Economic Recovery. COM (2012) 582 final, Brussels
Filipova, M. (2005). Managing of the Competitiveness in Brewery industry. In: 10-th National Symposium Quality, Competitiveness, Sustainable Development, University of National and World Economy Press, Sofia
Filipova, М. (2004). Increase the competitiveness of the breweries companies. Коrect, Sofia
Findlay, S. (2007). Outsourcing in pharma. Pharmaceutical Technology Europe, 19(5): 13-14
Georgiev, R. (2013). Strategirane i konturentosposobnost. PrintMedia, Sofia (in Bulgarian)
Glickman, S., J. McHutchison, E. Peterson, C. Cairns, R. Harrington, R. Califf, K. Schulman. (2009). The new Ethical and Scientific Implications of the Globalization of Clinical Research. England Journal of Medicine, 360: 816-823
Houbenova-Delisivkova, T. (2012). A worthy contribution to the scientific studies of modern capitalism and the international monetary and financial system. Economic Thought, 5 (168-170)
Hymer, S. (1976). The International Operations of Nation Firms: A Study of Foreign Direct Investment. Cambridge, MLT Press
Keremidchiev, S. (2013). Genesis and initial development of consulting market in Bulgaria. Economic Thought, 1: 26-44
Kettler, H. (2000). Consolidation and competition in the pharmaceutical industry. Based on papers delivered at the OHE Conference, London, 16 October 2000
Kirilov, B., E. Grigorov, I. Getov. (2011). Feasibility Study on the Use of Antioxidant Vitamins on the Bulgarian Market. Pharmacia, LVIII(1-4): 104-107
Madgerova, R., V. Kyurova. (2014). Definition, characteristics and problems of family business. Economics and Management, X(2): 97-105 (in Bulgarian)
Ministry of Health, Labour and Welfare. (2007). New vision for the pharmaceutical industry. Aiming at the industry with international competitive power taking the mission of innovation. Tokyo
Nedeltchev, D. (2004). Social capital. Prof. Marin Drinov, Sofia (in Bulgarian)
Petrova, E. (2014). Innovation in the Pharmaceutical Industry: The Process of Drug Discovery and Development. In: Ding M., Eliashberg J., Stremersch S. (eds.) Innovation and Marketing in the Pharmaceutical Industry. International Series in Quantitative Marketing, vol. 20. Springer, New York, NY
Rowberg, R. (2001). Pharmaceutical Research and Development: A Description and Analysis of the Process. Congressional Research Service Report for Congress. Library of Congress
Stoimenova, A., A. Savova, T. Benisheva, G. Petrova, M. Kamusheva. (2014). Pharmacoeconomic Evaluation for Reimbursement Purposes in Bulgaria: Recent Updates. Value in Health, 17(7): A448
Todorova, R. (2019). Good Clinical Practices in the New Reality. Student Scientific Yearbook. International Business School, Sofia
Wernicki, A. (2013). The End of the Golden Age of Antibiotics? Journal of Veterinary Science & Animal Husbandry, 1(1): e103
World Health Organization. (2011). WHO good manufacturing practices for pharmaceutical products: main principles. Technical Report Series, No. 961


Full Text: PDF (English)